Lycia Therapeutics (LYCA) insider trading
Insider activity, historical context and SEC filings · data through Oct 27, 2026
Insiders put their own money in: $37.7M of open-market buys. See how similar setups did below.
Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Purchase Venrock Healthcare Capital Partners Iii, L.P., 10% Owner bought 1,944,444 shares at $18.00 ($35.0M).
- Trade date
- Oct 26, 2026
- Disclosed to the SEC
- Oct 27, 2026
- Type
- Open-market purchase (code P)
Read the original SEC filing ↗All LYCA insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
Similar past setups: not applicable. There aren't enough comparable past cases for LYCA's latest buying to report odds. When insiders buy, this section shows how 16,899 similar past buys did over 90 days. How we calculate this →
Play with LYCA in the Research Lab
Pre-set to LYCA's latest insider buy of $10K or more (Oct 27, 2026: Venrock Healthcare Capital Partners Iii, L.P., $37.7M). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 16,899 past insider buys did.
Share price and insider trades
Price history unavailable.
Lycia Therapeutics insider trading at a glance (Oct 27, 2026): in the past 12 months, 1 insider bought $37.7M and 0 sold $0 of LYCA stock on the open market.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this
LYCA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $37.7M | 6 | — | 0 |
Valuation, profit and volume
Valuation figures for LYCA are refreshed each weekday; some aren't published for every company. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 Lycia Therapeutics, Inc. insider reported open-market purchases totaling $37.7M, while 0 insiders reported sales totaling $0.
What happened after LYCA insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Oct 27, 2026 | Venrock Healthcare Capital Partners Iii, L.P.10% Owner | $37.7M | pending | pending | pending |
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 27 NewSEC | Venrock Healthcare Capital Partners Iii, L.P.10% Owner | Buy | 1,944,4446,777,176 held (+40%) | $18.00 | $35.0M | — | — |
| Oct 27 NewSEC | Venrock Healthcare Capital Partners Iii, L.P.10% Owner | Buy | 31,0676,825,233 held (+0%) | $26.84 | $834K | — | — |
| Oct 27 NewSEC | Venrock Healthcare Capital Partners Iii, L.P.10% Owner | Buy | 28,37952,939 held (+116%) | $26.11 | $741K | — | — |
| Oct 27 NewSEC | Venrock Healthcare Capital Partners Iii, L.P.10% Owner | Buy | 24,560new position | $25.68 | $631K | — | — |
| Oct 27 NewSEC | Venrock Healthcare Capital Partners Iii, L.P.10% Owner | Buy | 8,7296,794,166 held (+0%) | $25.84 | $226K | — | — |
| Oct 27 NewSEC | Venrock Healthcare Capital Partners Iii, L.P.10% Owner | Buy | 8,2616,785,437 held (+0%) | $26.97 | $223K | — | — |
Insiders at Lycia Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners Iii, L.P.10% Owner | $37.7M | — | Oct 27, 2026 | — | — |
LYCA stock: common questions
Are Lycia Therapeutics, Inc. insiders buying LYCA stock?
In the past 12 months, 1 insiders reported open-market purchases of LYCA worth $37.7M. The latest was 10% Owner Venrock Healthcare Capital Partners Iii, L.P. bought $35.0M of LYCA at $18.00 — largest purchase by this insider in our records; raises the stake by 40%.
Are Lycia Therapeutics, Inc. insiders selling LYCA stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.